151 related articles for article (PubMed ID: 15844753)
1. Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias.
Molinuevo JL; Lladó A; Rami L
Am J Alzheimers Dis Other Demen; 2005; 20(2):77-85. PubMed ID: 15844753
[TBL] [Abstract][Full Text] [Related]
2. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.
Olivares D; Deshpande VK; Shi Y; Lahiri DK; Greig NH; Rogers JT; Huang X
Curr Alzheimer Res; 2012 Jul; 9(6):746-58. PubMed ID: 21875407
[TBL] [Abstract][Full Text] [Related]
3. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.
Thomas SJ; Grossberg GT
Clin Interv Aging; 2009; 4():367-77. PubMed ID: 19851512
[TBL] [Abstract][Full Text] [Related]
4. Memantine: Updating a rare success story in pro-cognitive therapeutics.
Karimi Tari P; Parsons CG; Collingridge GL; Rammes G
Neuropharmacology; 2024 Feb; 244():109737. PubMed ID: 37832633
[TBL] [Abstract][Full Text] [Related]
5. Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.
Folch J; Busquets O; Ettcheto M; Sánchez-López E; Castro-Torres RD; Verdaguer E; Garcia ML; Olloquequi J; Casadesús G; Beas-Zarate C; Pelegri C; Vilaplana J; Auladell C; Camins A
J Alzheimers Dis; 2018; 62(3):1223-1240. PubMed ID: 29254093
[TBL] [Abstract][Full Text] [Related]
6. Memantine's double duty? Investigating its impact on epilepsy control in Alzheimer's disease.
Rayala H; Kapur J; El-Haija HA; Parikh P; Zawar I
Epileptic Disord; 2024 Apr; 26(2):261-263. PubMed ID: 38334219
[No Abstract] [Full Text] [Related]
7. Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid β1-42.
Rozumna NM; Hanzha VV; Lukyanetz EA
Front Neurosci; 2023; 17():1269664. PubMed ID: 38144212
[TBL] [Abstract][Full Text] [Related]
8. Current and future treatments for Alzheimer's disease.
Yiannopoulou KG; Papageorgiou SG
Ther Adv Neurol Disord; 2013 Jan; 6(1):19-33. PubMed ID: 23277790
[TBL] [Abstract][Full Text] [Related]
9. New Hybrid Structures Based on Memanthine and Edaravone Molecules.
Grigoriev VV; Shevtsova EF; Aksinenko AY; Veselov IM; Goreva TV; Gabrelyan AV; Bachurin SO
Dokl Biochem Biophys; 2023 Oct; 512(1):284-287. PubMed ID: 38093132
[TBL] [Abstract][Full Text] [Related]
10. Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence.
Barron S; Lewis B; Wellmann K; Carter M; Farook J; Ring J; Rogers DT; Holley R; Crooks P; Littleton J
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):129-44. PubMed ID: 22574674
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?
Robles A
Open Neurol J; 2009 Apr; 3():27-44. PubMed ID: 19461897
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological models in Alzheimer's disease research.
Gilles C; Ertlé S
Dialogues Clin Neurosci; 2000 Sep; 2(3):247-55. PubMed ID: 22034060
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Promising therapeutic strategies for Alzheimer's disease: a focus on amyloid-β targeting.
Bigi A; Limbocker R; Cecchi C
Front Neurosci; 2024; 18():1415641. PubMed ID: 38726032
[No Abstract] [Full Text] [Related]
14. Correction to "Pharmacological Characterizations of anti-Dementia Memantine Nitrate via Neuroprotection and Vasodilation
Mak S; Liu Z; Wu L; Guo B; Luo F; Liu Z; Hu S; Wang J; Cui G; Sun Y; Wang Y; Zhang G; Han Y; Zhang Z
ACS Chem Neurosci; 2024 May; 15(10):2089-2090. PubMed ID: 38679870
[No Abstract] [Full Text] [Related]
15. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.
Parsons CG; Stöffler A; Danysz W
Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591
[TBL] [Abstract][Full Text] [Related]
16. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
Esposito Z; Belli L; Toniolo S; Sancesario G; Bianconi C; Martorana A
CNS Neurosci Ther; 2013 Aug; 19(8):549-55. PubMed ID: 23593992
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases.
Dong XX; Wang Y; Qin ZH
Acta Pharmacol Sin; 2009 Apr; 30(4):379-87. PubMed ID: 19343058
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
